CS logo
small CS logo
Perlmutter Cancer Center at NYU Langone Hospital-Long Island

Mineola, New York, United States
Cancer treatment center in Mineola, New York
120 Mineola Blvd Suite 500, Mineola, NY 11501

About Perlmutter Cancer Center at NYU Langone Hospital-Long Island


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Perlmutter Cancer Center at NYU Langone Hospital-Long Island


During the past decade, Perlmutter Cancer Center at NYU Langone Hospital-Long Island conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators



Clinical Trials Conditions at Perlmutter Cancer Center at NYU Langone Hospital-Long Island


According to Clinical.Site data, the most researched conditions in "Perlmutter Cancer Center at NYU Langone Hospital-Long Island" are "Abiraterone Acetate" (1 trials), "Androgens" (1 trials), "Antineoplastic Agents" (1 trials), "Antineoplastic Agents, Hormonal" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Perlmutter Cancer Center at NYU Langone Hospital-Long Island" in a lesser frequency.

Clinical Trials Intervention Types at Perlmutter Cancer Center at NYU Langone Hospital-Long Island


Most popular intervention types in "Perlmutter Cancer Center at NYU Langone Hospital-Long Island" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "Abiraterone" (1 trials), "Anastrozole" (1 trials), "CC-99282" (1 trials) and "Exemestane" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Perlmutter Cancer Center at NYU Langone Hospital-Long Island


The vast majority of trials in "Perlmutter Cancer Center at NYU Langone Hospital-Long Island" are 2 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at Perlmutter Cancer Center at NYU Langone Hospital-Long Island


Currently, there are NaN active trials in "Perlmutter Cancer Center at NYU Langone Hospital-Long Island". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Perlmutter Cancer Center at NYU Langone Hospital-Long Island, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Perlmutter Cancer Center at NYU Langone Hospital-Long Island, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".